The report identifies key companies involved in the protein therapeutics market, such as
- Abbott Laboratories
- Amgen Inc.
- Baxter International Inc.
- Eli Lilly and Company
- Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Merck & Co. Inc.
- Novo Nordisk A/S
- Pfizer Inc.
The rise in the occurrence of chronic diseases worldwide and a significant improvement of plasma-derived therapies have resulted in an increased demand for protein therapeutics. Along with the upsurge in demand, the global market is also driven by a torrent of awareness among the populace concerning the benefits of protein therapeutics. Key market players are anticipated to receive lucrative opportunities owing to the adoption of protein therapeutics for novel indications along with the untapped potential in developing countries. However, high expenses associated with therapeutic proteins and harsh government regulations towards these class of medicines hinder market growth.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/60
The report segments the global protein therapeutics market based on product, application, and geography. By product, the market is demarcated into monoclonal antibodies, insulin, fusion protein, erythropoietin, interferon, human growth hormone, and follicle stimulating hormone. In 2016, monoclonal antibodies registered the largest share in the global market in terms of generated revenue. The sub-segment is expected to continue its dominance during the forecast period, owing to their necessity and applicability in treating myriad chronic disorders.
“Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) – Global Opportunity Analysis and Industry Forecast, 2017-2023”. The report valued the global protein therapeutics market at $140,109 million in 2016 and expected it to reach $217,591 million by 2023, growing at a CAGR of 6.5% during the forecast period, 2017-2023.
The report also divides the market based on application. The sub-segments comprise metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others. Metabolic disorders hold a dominant position over the market in 2016 and are expected to continue to maintain the lead during the forecast period as well. In 2016, North America generated the highest revenue in the global therapeutics market. However, with a CAGR of 7.6%, Asia-Pacific is expected to grow at the fastest rate due to an increase in awareness about protein therapeutics-based treatments and a considerable rise in subsequent applications.
Scope of the Report:
Report Attribute | Details |
Market size available for years | 2017-2023 |
Base year considered | 2018 |
Forecast period | 2017-2023 |
Forecast units | Value (USD) |
Segments covered | By Product, By Application, By Geography |
Geographies covered | North America, Europe, Asia-Pacific, LAMEA |
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research